Clinical trial
Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care
NCT07246265 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care
- Lead sponsor
- University Hospital, Tours
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 5, 2026
- Completion date
- September 30, 2028
- Enrollment
- 100 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
acute chest syndrome, glomerular hyperfiltration, sickle cell disease, sickle cell nephropathy, vaso-occlusive crises